Food is medicine. And leveraging its power to heal isn’t a new concept.
In fact, roughly 50% of all small-molecule medicines are derived from nature.
But what if we could use AI to better understand the biology of the millions of molecules humans already consume? What if we could then apply this information to identify new treatments for chronic diseases?
This week, we’re welcoming the CEO of Montai Health, Margo Georgiadis, to the podcast to discuss their AI platform that uses literature and wet lab experiments to analyse “the most privileged chemistry on Earth” to find new treatments for chronic diseases.
Join Patrick and Margo for this hour-long episode, as they explore how Montai is leveraging technology to develop medicines based on the chemistry of food. From why ‘Anthromeolecules’ represent an abundant source of opportunities for drug discovery to the potential for AI to accelerate drug discovery and healthcare, this jam-packed episode celebrates the intersection of nature and technology.
After listening to this hour-long episode, you will:
understand Anthromolecules, and how the millions of molecules we already consume could be developed into new medicines
know how AI can be leveraged to build a ‘ChatGPT’ to learn the language of biology and chemistry
recognise Margo’s journey into biotech and healthcare, from her roots in the tech industry
EP 96: CEO of Montai Health, Margo Georgiadis, talks the intersection of nature and AI | The Genetics Podcast - Listen or read transcript on Metacast
